Summary
HCA Healthcare, Inc. (HCA) filed an 8-K on April 11, 2022, to announce the adoption of the 2022 Senior Officer Performance Excellence Program (Senior Officer PEP). This program outlines the performance-based award structure for the company's executive officers for the fiscal year 2022. The primary goal is to align executive compensation with key performance indicators, thereby incentivizing strong operational and clinical performance. The Senior Officer PEP is designed with a dual focus: 80% of the award opportunity is tied to the achievement of specified Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) targets, and the remaining 20% is linked to the attainment of critical quality metrics. This structure aims to ensure that executives are motivated to drive both financial profitability and high-quality patient care. The plan details specific award percentages of base salary for various named executive officers, including the CEO, CFO, and Group Presidents, with payout structures ranging from threshold to maximum performance levels.
Key Highlights
- 1HCA Healthcare has implemented the 2022 Senior Officer Performance Excellence Program (Senior Officer PEP) to govern executive compensation for the year.
- 2Executive awards under the Senior Officer PEP are weighted 80% on EBITDA targets and 20% on quality metrics.
- 3The EBITDA component for Group Presidents is further divided, with 50% based on Company EBITDA and 50% on their respective Group's EBITDA.
- 4Key quality metrics include Healthcare-Associated Infections, Core Measures, Comprehensive Healthcare Outcomes Information System (CHOIS) Risk-Adjusted Indices, and Care Experience.
- 5Target award opportunities for 2022 are set as a percentage of base salary, with the CEO eligible for 170%, the CFO for 125%, and Group Presidents for 110%.
- 6Payouts for EBITDA performance range from 25% of target for threshold performance to a maximum of 200% for maximum performance, with straight-line interpolation for levels in between.
- 7Awards are payable solely in cash, with provisions for adjustments and clawbacks under specific circumstances, including restatements or misconduct.